New insights into the effects of microbiome and its derived metabolites on targeted immunotherapy

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Elghannam M.T.; Hassanien M.H.; Ameen Y.A.R.; Turky E.A.; ELattar G.M.; ELRay A.A.; ELTalkawy M.D.

Journal: Journal of the Egyptian National Cancer Institute

Publisher: Springer Science and Business Media Deutschland GmbH

Publication Date: 16 November 2025

Volume / Issue: Volume 37 / Issue 1

Article No.: 74

ISSN: 11100362

DOI: 10.1186/s43046-025-00330-x

Scopus: View on Scopus

PubMed: 41243049

Document Type: Review

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Elghannam M.T., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; Hassanien M.H., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; Ameen Y.A.R., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; Turky E.A., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; ELattar G.M., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; ELRay A.A., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt; ELTalkawy M.D., Hepatogastroenterology deparment, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

The significance of gut bacteria and their byproducts is gaining greater recognition, especially in the realm of immunotherapy. An imbalance in gut bacteria or their byproducts is intricately linked to the onset, progression, and treatment of cancer. Metabolites derived from gut microbiota, including short-chain fatty acids (SCFAs), secondary bile acids (SBAs), indole derivatives, and trimethylamine oxide (TMAO), engage with cellular targets to initiate intracellular signaling pathways. These signals are conveyed to the cell, influencing its growth. Targeted therapies encompass a complex and ever-evolving area that is crucial in cancer management. Nonetheless, it is vital to recognize that targeted therapy encounters a multitude of challenges. Factors influencing the success of targeted therapy include drug resistance resulting from prolonged use, side effects, and variations in genetic mutations, tumor diversity, and the complex nature of the tumor microenvironment. Recently, we have deepened our understanding of the relationship between the gut microbiome and anticancer targeted therapies. This is one face of the molecular pathologic epidemiology. This prompts us to investigate promising treatment strategies linked to these gut bacteria and their metabolites, thereby unlocking new possibilities for targeted anticancer therapies. © The Author(s) 2025.


Keywords

Bacterial metabolites; Drug-resistance; Gut microbiota; Targeted therapy; Bile Acids and Salts; Fatty Acids, Volatile; Gastrointestinal Microbiome; Humans; Immunotherapy; Indoles; Methylamines; Molecular Targeted Therapy; Neoplasms; Tumor Microenvironment; bile acid; indole derivative; short chain fatty acid; trimethylamine oxide; methylamine; trimethyloxamine; volatile fatty acid; antineoplastic activity; cancer inhibition; drug resistance; drug therapy; gut microbiome; human; intestine flora; intracellular signaling; metabolite; microbiome; nonhuman; pharmacology; review; signal transduction; drug effect; immunology; metabolism; microbiology; molecularly targeted therapy; neoplasm; procedures; therapy


Citation Information

Scopus Citations: 1


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]